Quantcast

Latest Estrogen Stories

2011-08-16 23:04:25

African-American women are at higher risk for hormone receptor-negative breast cancer, one of the most difficult subtypes to treat, but this risk could be ameliorated somewhat by breast-feeding their children. "African-American women are more likely to have had a greater number of full-term births and less likely to have breast-fed their babies," said Julie Palmer, Sc.D., professor of epidemiology at the Slone Epidemiology Center at Boston University. "This study shows a clear link between...

2011-08-15 12:05:51

Georgetown researchers discover in mice that a higher level of aromatase in breast tissue is more dangerous than excess production of estrogen receptors -- a finding that could impact prevention strategies Could some women who naturally produce excess aromatase in their breasts have an increased risk of developing breast cancer? Results of a new animal study suggests that may be the case, say researchers at Georgetown Lombardi Comprehensive Cancer Center, a part of Georgetown University...

2011-08-09 07:00:00

INDIANAPOLIS, Aug. 9, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that data on EVISTA® (raloxifene HCl tablets) therapy for more than three years was published online in Current Medical Research & Opinion. The review includes summaries of previously published information; new, previously unpublished observations; and new data on EVISTA use. EVISTA is indicated for the treatment of osteoporosis in postmenopausal women and reduction in risk of...

2011-08-09 00:00:03

Nutri-Med Logic Corp disputes the assertion that calcium supplementation is the solution, at least in women with Osteoporosis, and state that an anti-inflammatory food such as Omega-3 would be as important, if not more. Miami, FL (PRWEB) August 08, 2011 Nutri-Med Logic Corp.: Calcium or Omega-3? Is one more important than the other for Osteoporosis? The August issue of International Journal of Rheumatic Disease only emphasizes on the need for supplementation of Calcium in Osteoporosis (doi:...

2011-07-26 12:28:00

Company expects to file New Drug Application QUÓ°BEC CITY, July 26, 2011 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced completion of its Phase 3 study with AEZS-130 as the first oral diagnostic test for Adult Growth Hormone Deficiency (AGHD). The Company is currently proceeding with detailed analyses of the data and preparing for a pre-New Drug Application (NDA) meeting with the U.S. Food and Drug...

2011-07-26 14:04:51

Study shows menopause does not raise risk for diabetes, but weight loss and exercise does lower risk for some postmenopausal women Menopause has little to no impact on whether women become more susceptible to diabetes, according to a one-of-a-kind study. Postmenopausal women had no higher risk for diabetes whether they experienced natural menopause or had their ovaries removed, according to the national clinical trial of 1,237 women at high risk for diabetes, ages 40 to 65. "In our study,...

2011-07-25 07:00:00

EMERYVILLE, Calif., July 25, 2011 /PRNewswire/ -- Bionovo, Inc. (NASDAQ: BNVI), a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, announced today the successful completion of 13 weeks repeat dose animal toxicology studies with Menerba. "Prior to Phase 3 initiation we were required by FDA to complete two 13 weeks repeat dose animal toxicology studies," commented Dr. Isaac Cohen, chairman and chief executive...

2011-07-19 14:39:36

Changes in bone density in oral contraceptive users depends on age and hormone dose Birth control pills may reduce a woman's bone density, according to a study published online July 13 in The Journal of Clinical Endocrinology and Metabolism by Group Health Research Institute (GHRI) scientists. Impacts on bone were small, depended on the woman's age and the pill's hormone dose, and did not appear until about two years of use. The study size and design allowed the researchers to focus on 14- to...

2011-07-12 07:37:22

(Ivanhoe Newswire) "“ The male hormone androgen may spark the growth of some breast cancer tumors in women, according to this study. "We identified a novel subtype of breast tumor which grows in response to androgen but not estrogen, and have uncovered the signaling pathways involved in its growth," senior author Myles Brown, MD, was quoted as saying. "And we've demonstrated that drugs capable of blocking these pathways, including the receptor for androgen itself, can inhibit tumor...

2011-07-11 20:40:19

Although it sounds like a case of gender confusion on a molecular scale, the male hormone androgen spurs the growth of some breast tumors in women. In a new study, scientists at Dana-Farber Cancer Institute provide the first details of the cancer cell machinery that carries out the hormone's relentless growth orders. The study, published the journal Cancer Cell on July 12, provides scientists with several inviting targets "“ cell proteins that snap into action in response to androgen...


Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related